256 related articles for article (PubMed ID: 22593588)
21. Molecular genetics of Turner syndrome: correlation with clinical phenotype and response to growth hormone therapy.
Tsezou A; Hadjiathanasiou C; Gourgiotis D; Galla A; Kavazarakis E; Pasparaki A; Kapsetaki M; Sismani C; Theodoridis C; Patsalis PC; Moschonas N; Kitsiou S
Clin Genet; 1999 Dec; 56(6):441-6. PubMed ID: 10665663
[TBL] [Abstract][Full Text] [Related]
22. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Massa GG; Rouwe CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 1999 Dec; 84(12):4607-12. PubMed ID: 10599727
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial.
Davenport ML; Crowe BJ; Travers SH; Rubin K; Ross JL; Fechner PY; Gunther DF; Liu C; Geffner ME; Thrailkill K; Huseman C; Zagar AJ; Quigley CA
J Clin Endocrinol Metab; 2007 Sep; 92(9):3406-16. PubMed ID: 17595258
[TBL] [Abstract][Full Text] [Related]
24. Parental origin of normal X chromosomes in Turner syndrome patients with various karyotypes: implications for the mechanism leading to generation of a 45,X karyotype.
Uematsu A; Yorifuji T; Muroi J; Kawai M; Mamada M; Kaji M; Yamanaka C; Momoi T; Nakahata T
Am J Med Genet; 2002 Aug; 111(2):134-9. PubMed ID: 12210339
[TBL] [Abstract][Full Text] [Related]
25. Gonadoblastoma in Turner syndrome patients with nonmosaic 45,X karyotype and Y chromosome sequences.
Canto P; Kofman-Alfaro S; Jiménez AL; Söderlund D; Barrón C; Reyes E; Méndez JP; Zenteno JC
Cancer Genet Cytogenet; 2004 Apr; 150(1):70-2. PubMed ID: 15041227
[TBL] [Abstract][Full Text] [Related]
26. Psychosocial functioning, self-perception and body image and their auxologic correlates in growth hormone and oestrogen-treated young adult women with Turner syndrome.
Lagrou K; Froidecoeur C; Verlinde F; Craen M; De Schepper J; François I; Massa G;
Horm Res; 2006; 66(6):277-84. PubMed ID: 16946621
[TBL] [Abstract][Full Text] [Related]
27. Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome.
Binder G; Trebar B; Baur F; Schweizer R; Ranke MB
Clin Endocrinol (Oxf); 2008 Apr; 68(4):567-72. PubMed ID: 17973940
[TBL] [Abstract][Full Text] [Related]
28. Treatment outcome in Turner syndrome.
Parvin M; Roche E; Costigan C; Hoey HM
Ir Med J; 2004 Jan; 97(1):12, 14-5. PubMed ID: 15055914
[TBL] [Abstract][Full Text] [Related]
29. Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone.
Soriano-Guillen L; Coste J; Ecosse E; Léger J; Tauber M; Cabrol S; Nicolino M; Brauner R; Chaussain JL; Carel JC
J Clin Endocrinol Metab; 2005 Sep; 90(9):5197-204. PubMed ID: 15998771
[TBL] [Abstract][Full Text] [Related]
30. Short- and long-term (final height) growth responses to growth hormone (GH) therapy in patients with Turner syndrome: correlation of growth response to stimulated GH levels, spontaneous GH secretion, and karyotype.
Schmitt K; Haeusler G; Blümel P; Plöchl E; Frisch H
Horm Res; 1997; 47(2):67-72. PubMed ID: 9030970
[TBL] [Abstract][Full Text] [Related]
31. Paternal X could relate to arithmetic function; study of cognitive function and parental origin of X chromosome in Turner syndrome.
Ergür AT; Ocal G; Berberoglu M; Tekin M; Kiliç BG; Aycan Z; Kutlu A; Adiyaman P; Siklar Z; Akar N; Sahin A; Akçayöz D
Pediatr Int; 2008 Apr; 50(2):172-4. PubMed ID: 18353053
[TBL] [Abstract][Full Text] [Related]
32. [Anthropometric parameters prognosticating a good final height in patients with Turner syndrome during growth hormone therapy].
Kucharska AM; Majcher A; Rymkiewicz-Kluczyńska B
Pediatr Endocrinol Diabetes Metab; 2007; 13(3):165-70. PubMed ID: 17880828
[TBL] [Abstract][Full Text] [Related]
33. Paternally derived der(7)t(Y;7)(p11.1 approximately 11.2;p22.3)dn in a mosaic case with Turner syndrome.
Polityko AD; Khurs OM; Kulpanovich AI; Mosse KA; Solntsava AV; Rumyantseva NV; Naumchik IV; Liehr T; Weise A; Mkrtchyan H
Eur J Med Genet; 2009; 52(4):207-10. PubMed ID: 19375526
[TBL] [Abstract][Full Text] [Related]
34. [Prediction of final height in girls with Turner syndrome treated with growth hormone].
Morin A; Guimarey L; Santucci Z; Apezteguia M
Medicina (B Aires); 2000; 60(5 Pt 1):551-4. PubMed ID: 11188890
[TBL] [Abstract][Full Text] [Related]
35. Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial.
Stephure DK;
J Clin Endocrinol Metab; 2005 Jun; 90(6):3360-6. PubMed ID: 15784709
[TBL] [Abstract][Full Text] [Related]
36. [Effect of estrogen therapy on the growth of Turner syndrome in girls treated with growth hormone].
Morin A; Guimarey L; Apezteguia M; Santucci Z
Medicina (B Aires); 2001; 61(3):271-4. PubMed ID: 11474872
[TBL] [Abstract][Full Text] [Related]
37. Influence of X chromosome and hormones on human brain development: a magnetic resonance imaging and proton magnetic resonance spectroscopy study of Turner syndrome.
Cutter WJ; Daly EM; Robertson DM; Chitnis XA; van Amelsvoort TA; Simmons A; Ng VW; Williams BS; Shaw P; Conway GS; Skuse DH; Collier DA; Craig M; Murphy DG
Biol Psychiatry; 2006 Feb; 59(3):273-83. PubMed ID: 16139817
[TBL] [Abstract][Full Text] [Related]
38. Effect of growth hormone therapy on severe short stature and skeletal deformities in a patient with combined Turner syndrome and Langer mesomelic dysplasia.
Shah BC; Moran ES; Zinn AR; Pappas JG
J Clin Endocrinol Metab; 2009 Dec; 94(12):5028-33. PubMed ID: 19850687
[TBL] [Abstract][Full Text] [Related]
39. Adult height in Turkish patients with Turner syndrome without growth hormone treatment.
Bereket A; Turan S; Elçioğlu N; Hacihanefioğlu S; Memioğlu N; Baş F; Bundak R; Darendeliler F; Günöz H; Saka N; Ercan O; Arslanoğlu I; Işgüven P; Yildiz M; Can S; Ozerkan E; Coker M; Darcan S; Ozkan B; Orbak Z; Oztaş S; Palandüz S; Sezgin I; Atabek E; Erkul I; Erdoğan G
Turk J Pediatr; 2008; 50(5):415-7. PubMed ID: 19102043
[TBL] [Abstract][Full Text] [Related]
40. Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment.
Visser JA; Hokken-Koelega AC; Zandwijken GR; Limacher A; Ranke MB; Flück CE
Hum Reprod; 2013 Jul; 28(7):1899-907. PubMed ID: 23539612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
